Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
Open Access
- 22 December 2016
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 389 (10068), 505-518
- https://doi.org/10.1016/s0140-6736(16)32621-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysisBMC Medicine, 2016
- Changes in the primary outcome in Ebola vaccine trial – Authors' replyThe Lancet, 2016
- Ebola Virus Disease among Male and Female Persons in West AfricaThe New England Journal of Medicine, 2016
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strainScience, 2015
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialThe Lancet, 2015
- Interim results from a phase 3 Ebola vaccine study in GuineaThe Lancet, 2015
- Transmission of Ebola Viruses: What We Know and What We Do Not KnowmBio, 2015
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg virusesVaccine, 2008
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman PrimatesPLoS Pathogens, 2008
- Effective Post-Exposure Treatment of Ebola InfectionPLoS Pathogens, 2007